| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM19
|
ADAM metallopeptidase domain 19
|
|
ADAMTS18
|
ADAM metallopeptidase with thrombospondin type 1 motif, 18
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADGRG6
|
adhesion G protein-coupled receptor G6
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIM2
|
absent in melanoma 2
|
|
AJAP1
|
adherens junctions associated protein 1
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALX4
|
ALX homeobox 4
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPTL2
|
angiopoietin-like 2
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APC
|
adenomatous polyposis coli
|
|
APCDD1
|
adenomatosis polyposis coli down-regulated 1
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like)
|
|
ARID4A
|
AT rich interactive domain 4A (RBP1-like)
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ARRB1
|
arrestin, beta 1
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATF7IP
|
activating transcription factor 7 interacting protein
|
|
ATF7IP2
|
activating transcription factor 7 interacting protein 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATXN2
|
ataxin 2
|
|
ATXN8
|
ataxin 8
|
|
AXIN2
|
axin 2
|
|
B4GALNT2
|
beta-1,4-N-acetyl-galactosaminyl transferase 2
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEX1
|
brain expressed, X-linked 1
|
|
BEX2
|
brain expressed X-linked 2
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP8B
|
bone morphogenetic protein 8b
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BTG4
|
B-cell translocation gene 4
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
CADM1
|
cell adhesion molecule 1
|
|
CAGE1
|
cancer antigen 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBX1
|
chromobox homolog 1
|
|
CBX5
|
chromobox homolog 5
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD34
|
CD34 molecule
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD7
|
CD7 molecule
|
|
CD70
|
CD70 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD8B
|
CD8b molecule
|
|
CD9
|
CD9 molecule
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CDX1
|
caudal type homeobox 1
|
|
CDYL
|
chromodomain protein, Y-like
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CENPA
|
centromere protein A
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
|
|
CLDN11
|
claudin 11
|
|
CLDN4
|
claudin 4
|
|
CLU
|
clusterin
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
COL15A1
|
collagen, type XV, alpha 1
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRYAA
|
crystallin, alpha A
|
|
CSAG2
|
CSAG family, member 2
|
|
CST6
|
cystatin E/M
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTTN
|
cortactin
|
|
CUL4B
|
cullin 4B
|
|
CUL5
|
cullin 5
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DACT2
|
dishevelled-binding antagonist of beta-catenin 2
|
|
DACT3
|
dishevelled-binding antagonist of beta-catenin 3
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DAZL
|
deleted in azoospermia-like
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DERL3
|
derlin 3
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLX3
|
distal-less homeobox 3
|
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6
|
|
DNAJC15
|
DnaJ (Hsp40) homolog, subfamily C, member 15
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DOCK4
|
dedicator of cytokinesis 4
|
|
DOK4
|
docking protein 4
|
|
DOK7
|
docking protein 7
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPPA3
|
developmental pluripotency associated 3
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DSP
|
desmoplakin
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EDN2
|
endothelin 2
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EGR1
|
early growth response 1
|
|
EHMT1
|
euchromatic histone-lysine N-methyltransferase 1
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
ELOVL2
|
ELOVL fatty acid elongase 2
|
|
EMP3
|
epithelial membrane protein 3
|
|
EN1
|
engrailed homeobox 1
|
|
EP300
|
E1A binding protein p300
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA5
|
EPH receptor A5
|
|
EPHA7
|
EPH receptor A7
|
|
EPHB2
|
EPH receptor B2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FALEC
|
focally amplified long non-coding RNA in epithelial cancer
|
|
FAM43B
|
family with sequence similarity 43, member B
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FASN
|
fatty acid synthase
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FERMT2
|
fermitin family member 2
|
|
FEZF1
|
FEZ family zinc finger 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXA2
|
forkhead box A2
|
|
FOXE1
|
forkhead box E1
|
|
FOXM1
|
forkhead box M1
|
|
FOXP3
|
forkhead box P3
|
|
FRG1
|
FSHD region gene 1
|
|
FTO
|
fat mass and obesity associated
|
|
FXN
|
frataxin
|
|
GABRB1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GAST
|
gastrin
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GDF15
|
growth differentiation factor 15
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GH1
|
growth hormone 1
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GKN1
|
gastrokine 1
|
|
GKN2
|
gastrokine 2
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GNAS
|
GNAS complex locus
|
|
GPR1-AS
|
GPR1 antisense RNA
|
|
GPR26
|
G protein-coupled receptor 26
|
|
GPX3
|
glutathione peroxidase 3
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM5
|
glutathione S-transferase mu 5
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFZ
|
H2A histone family, member Z
|
|
H3F3A
|
H3 histone, family 3A
|
|
HAS2-AS1
|
HAS2 antisense RNA 1
|
|
HBB
|
hemoglobin, beta
|
|
HCG9
|
HLA complex group 9 (non-protein coding)
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC7
|
histone deacetylase 7
|
|
HDAC9
|
histone deacetylase 9
|
|
HHIP
|
hedgehog interacting protein
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HINT1
|
histidine triad nucleotide binding protein 1
|
|
HIPK1
|
homeodomain interacting protein kinase 1
|
|
HIST1H3F
|
histone cluster 1, H3f
|
|
HIST2H2AC
|
histone cluster 2, H2ac
|
|
HIST2H3A
|
histone cluster 2, H3a
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLTF
|
helicase-like transcription factor
|
|
HMCES
|
5-hydroxymethylcytosine (hmC) binding, ES cell-specific
|
|
HMGB1
|
high mobility group box 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXA4
|
homeobox A4
|
|
HOXA5
|
homeobox A5
|
|
HOXA9
|
homeobox A9
|
|
HOXB13
|
homeobox B13
|
|
HOXB4
|
homeobox B4
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRK
|
harakiri, BCL2 interacting protein
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA2
|
heat shock 70kDa protein 2
|
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNG
|
interferon, gamma
|
|
IFNK
|
interferon, kappa
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGK
|
immunoglobulin kappa locus
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL12A
|
interleukin 12A
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL32
|
interleukin 32
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ILK
|
integrin-linked kinase
|
|
INS
|
insulin
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGA9
|
integrin, alpha 9
|
|
JAG1
|
jagged 1
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLHDC7B
|
kelch domain containing 7B
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LARGE
|
like-glycosyltransferase
|
|
LARS2
|
leucyl-tRNA synthetase 2, mitochondrial
|
|
LECT1
|
leukocyte cell derived chemotaxin 1
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX6
|
LIM homeobox 6
|
|
LIF
|
leukemia inhibitory factor
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LINC-PINT
|
long intergenic non-protein coding RNA, p53 induced transcript
|
|
LMNA
|
lamin A/C
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPL
|
lipoprotein lipase
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRRC3B
|
leucine rich repeat containing 3B
|
|
LTA
|
lymphotoxin alpha
|
|
LTF
|
lactotransferrin
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBD3
|
methyl-CpG binding domain protein 3
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MED19
|
mediator complex subunit 19
|
|
MED26
|
mediator complex subunit 26
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR101-2
|
microRNA 101-2
|
|
MIR10A
|
microRNA 10a
|
|
MIR122
|
microRNA 122
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR129-2
|
microRNA 129-2
|
|
MIR139
|
microRNA 139
|
|
MIR141
|
microRNA 141
|
|
MIR145
|
microRNA 145
|
|
MIR152
|
microRNA 152
|
|
MIR17
|
microRNA 17
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR182
|
microRNA 182
|
|
MIR185
|
microRNA 185
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR199B
|
microRNA 199b
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR203A
|
microRNA 203a
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR212
|
microRNA 212
|
|
MIR219A1
|
microRNA 219a-1
|
|
MIR22
|
microRNA 22
|
|
MIR224
|
microRNA 224
|
|
MIR23B
|
microRNA 23b
|
|
MIR29C
|
microRNA 29c
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR369
|
microRNA 369
|
|
MIR370
|
microRNA 370
|
|
MIR371A
|
microRNA 371a
|
|
MIR372
|
microRNA 372
|
|
MIR374A
|
microRNA 374a
|
|
MIR375
|
microRNA 375
|
|
MIR376C
|
microRNA 376c
|
|
MIR429
|
microRNA 429
|
|
MIR449A
|
microRNA 449a
|
|
MIR452
|
microRNA 452
|
|
MIR487B
|
microRNA 487b
|
|
MIR512-1
|
microRNA 512-1
|
|
MIR512-2
|
microRNA 512-2
|
|
MIR568
|
microRNA 568
|
|
MIR632
|
microRNA 632
|
|
MIR99A
|
microRNA 99a
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7C
|
microRNA let-7c
|
|
MIRLET7E
|
microRNA let-7e
|
|
MLH1
|
mutL homolog 1
|
|
MMACHC
|
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MPP3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)
|
|
MRPL41
|
mitochondrial ribosomal protein L41
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSMB
|
microseminoprotein, beta-
|
|
MSX1
|
msh homeobox 1
|
|
MT3
|
metallothionein 3
|
|
MTA1
|
metastasis associated 1
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTO1
|
mitochondrial tRNA translation optimization 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC17
|
mucin 17, cell surface associated
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYEOV
|
myeloma overexpressed
|
|
MYO18B
|
myosin XVIIIB
|
|
MYOCD
|
myocardin
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NDUFB6
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIL3
|
nuclear factor, interleukin 3 regulated
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPY
|
neuropeptide Y
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NSUN4
|
NOP2/Sun domain family, member 4
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUMB
|
numb homolog (Drosophila)
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OSCP1
|
organic solute carrier partner 1
|
|
OSMR
|
oncostatin M receptor
|
|
OXTR
|
oxytocin receptor
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PCDH10
|
protocadherin 10
|
|
PCDH11X
|
protocadherin 11 X-linked
|
|
PCDH8
|
protocadherin 8
|
|
PDCD1
|
programmed cell death 1
|
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PER1
|
period circadian clock 1
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PIWIL1
|
piwi-like RNA-mediated gene silencing 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLK1
|
polo-like kinase 1
|
|
PLK4
|
polo-like kinase 4
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU2F3
|
POU class 2 homeobox 3
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDM5
|
PR domain containing 5
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PROM1
|
prominin 1
|
|
PROX1
|
prospero homeobox 1
|
|
PRTFDC1
|
phosphoribosyl transferase domain containing 1
|
|
PSEN1
|
presenilin 1
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PVR
|
poliovirus receptor
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB6C
|
RAB6C, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RASD1
|
RAS, dexamethasone-induced 1
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF10
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
|
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
REST
|
RE1-silencing transcription factor
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RING1
|
ring finger protein 1
|
|
RND3
|
Rho family GTPase 3
|
|
RNF111
|
ring finger protein 111
|
|
RNF2
|
ring finger protein 2
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RRAD
|
Ras-related associated with diabetes
|
|
RREB1
|
ras responsive element binding protein 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A6
|
S100 calcium binding protein A6
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SEPT9
|
septin 9
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETD7
|
SET domain containing (lysine methyltransferase) 7
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SFMBT2
|
Scm-like with four mbt domains 2
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SFTPA1
|
surfactant protein A1
|
|
SGPL1
|
sphingosine-1-phosphate lyase 1
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIN3B
|
SIN3 transcription regulator family member B
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT6
|
sirtuin 6
|
|
SIRT7
|
sirtuin 7
|
|
SLBP
|
stem-loop binding protein
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC22A8
|
solute carrier family 22 (organic anion transporter), member 8
|
|
SLC25A43
|
solute carrier family 25, member 43
|
|
SLC26A2
|
solute carrier family 26 (anion exchanger), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD2
|
SMAD family member 2
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMARCE1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
|
|
SMCHD1
|
structural maintenance of chromosomes flexible hinge domain containing 1
|
|
SMOX
|
spermine oxidase
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMS
|
spermine synthase
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRPN
|
small nuclear ribonucleoprotein polypeptide N
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOX1
|
SRY (sex determining region Y)-box 1
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SP1
|
Sp1 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
SULF2
|
sulfatase 2
|
|
SUPT6H
|
suppressor of Ty 6 homolog (S. cerevisiae)
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SUV39H2
|
suppressor of variegation 3-9 homolog 2 (Drosophila)
|
|
SUV420H1
|
suppressor of variegation 4-20 homolog 1 (Drosophila)
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNM
|
synemin, intermediate filament protein
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAF5
|
TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBX21
|
T-box 21
|
|
TBX5
|
T-box 5
|
|
TCF21
|
transcription factor 21
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TDRD1
|
tudor domain containing 1
|
|
TEAD4
|
TEA domain family member 4
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFF1
|
trefoil factor 1
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR8
|
toll-like receptor 8
|
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
|
TMEM59
|
transmembrane protein 59
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSG101
|
tumor susceptibility 101
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSIX
|
TSIX transcript, XIST antisense RNA
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUSC5
|
tumor suppressor candidate 5
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
UHRF2
|
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
UQCC1
|
ubiquinol-cytochrome c reductase complex assembly factor 1
|
|
UQCRH
|
ubiquinol-cytochrome c reductase hinge protein
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
USP28
|
ubiquitin specific peptidase 28
|
|
UTF1
|
undifferentiated embryonic cell transcription factor 1
|
|
VAPA
|
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNK2
|
WNK lysine deficient protein kinase 2
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XAF1
|
XIAP associated factor 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB2
|
zinc finger and BTB domain containing 2
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZMPSTE24
|
zinc metallopeptidase STE24
|
|
ZMYND10
|
zinc finger, MYND-type containing 10
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF154
|
zinc finger protein 154
|
|
ZNF160
|
zinc finger protein 160
|
